Industry Overview

Canada oncology information system market was valued at $1.3 billion in 2025 and is projected to reach $3.1 billion by 2035, growing at a CAGR of 8.9% from 2026 to 2035. Oncology information systems are advanced healthcare IT solutions designed to manage patient data, streamline oncology workflows, and support clinical decision-making across the entire cancer care continuum. These systems integrate information from multiple departments, including diagnostics, imaging, and treatment planning, enabling a more coordinated and comprehensive approach to cancer management. The market is primarily driven by the rising incidence of cancer, increasing demand for precision medicine, and the rapid digital transformation of healthcare infrastructure. Healthcare providers across Canada are increasingly adopting these systems to improve operational efficiency, enhance patient safety, and ensure more accurate and timely treatment delivery.

The growing integration of artificial intelligence and cloud-based technologies is further accelerating the evolution of oncology information systems by enabling real-time data analytics and personalized treatment strategies. In April 2026, Oracle expanded its partnership with Google Cloud to strengthen AI capabilities within its database platform, introducing advanced tools such as natural language querying to improve large-scale data analysis and decision-making efficiency. Similarly, in September 2025, Philips introduced advanced CT and MR innovations, including Rembra RT, Areta RT, and BlueSeal RT systems, aimed at enhancing precision in radiation oncology. These AI-powered imaging solutions improve tumor visualization, optimize treatment planning, and streamline clinical workflows. Collectively, such technological advancements are reinforcing the role of oncology information systems in improving data integration, enabling informed clinical decisions, and supporting the delivery of personalized cancer care across hospitals and cancer treatment centers.

Market Dynamics

AI-Powered Oncology Software Transforming Cancer Care Workflows

Software segment leads the market due to the widespread adoption of oncology information platforms that enhance data management and streamline clinical workflows. These solutions play a critical role in treatment planning, patient tracking, and integration with imaging and diagnostic systems. In January 2026, Elekta AB received U.S. FDA 510(k) clearance for its Elekta Evo CT-Linac, enabling advanced radiation oncology applications in clinical settings. The system incorporates AI-driven imaging to improve tumor visualization, treatment precision, and clinical decision-making. Such advancements are strengthening oncology information systems by improving data integration, workflow efficiency, and personalized cancer care delivery. 

Rising Demand for Integration Services Driving Oncology IT Expansion

Services segment is experiencing strong growth due to increasing demand for system implementation, maintenance, and training support. Healthcare providers rely on these services to ensure seamless integration of oncology information systems with existing IT infrastructure. In March 2026, CompuGroup Medical introduced targeted innovations to expand its cloud, platform, and AI-driven healthcare IT solutions. These enhancements improve clinical workflows, data management, and interoperability across healthcare settings. Such developments are strengthening oncology information systems by enabling efficient data processing and advancing digital healthcare capabilities.

Market Segmentation

• Based on product type, the market is segmented into software and services.
• Based on application, the market is segmented into medical oncology, radiation oncology, and surgical oncology.
• Based on end-user, the market is segmented into hospitals, cancer treatment centers, and research & academic institutes.

AI-Driven Radiation Oncology Transforming Precision Cancer Care

Radiation oncology continues to lead the application segment due to its strong reliance on advanced treatment planning and integrated data systems. Oncology information systems play a vital role in optimizing radiation therapy workflows and ensuring high treatment accuracy. In May 2025, RaySearch Laboratories launched RayStation v2025, featuring AI-driven automated planning and deep learning capabilities. The platform enhances workflow efficiency, reduces planning time, and enables more consistent and personalized treatment approaches. Such advancements are strengthening oncology information systems by improving data integration and supporting more informed clinical decision-making in cancer care.

Market Players Outlook

The major companies operating in the Canada oncology information system market include McKesson Corporation, Siemens Healthineers, GE HealthCare, Philips Healthcare, and Oracle Health, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

Recent Development

• In April 2026, Epic announced the return of its Open@Epic conference to advance healthcare data sharing and interoperability across digital health systems. The initiative highlights rapid growth in connected health apps and patient-directed data exchange, with billions of API transactions supporting integrated care delivery. Such developments strengthen healthcare IT infrastructure, supporting oncology information systems through improved data integration, interoperability, and clinical workflow efficiency.

• In May 2025, Siemens Healthineers and Varian Medical Systems showcased an integrated oncology portfolio at ESTRO 2025, focusing on improving workflow efficiency and patient outcomes across the cancer care continuum. The company introduced enhancements to its ARIA CORE oncology management system, including automation and improved software integration to streamline clinical workflows.

The Report Covers

• Market value data analysis of 2025 and forecast to 2035.
• Annualized market revenues ($ million) for each market segment.
• Key companies operating in the Canada oncology information system market
• Based on the availability of data, information related to new protections and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.